High-flow Nasal Oxygen: Physiology and Clinical Applications
- PMID: 39233573
- DOI: 10.1097/AIA.0000000000000449
High-flow Nasal Oxygen: Physiology and Clinical Applications
Conflict of interest statement
M.J.F. has received travel support, lecture fees and equipment for academic trials from Fisher and Paykel Healthcare. A.P. has received funding support for speaking, consulting and research from Fisher and Paykel Healthcare. C.L. has no conflict of interest to disclose.
References
-
- Parke RL, Bloch A, McGuinness SP. Effect of very-high-flow nasal therapy on airway pressure and end-expiratory lung impedance in healthy volunteers. Respir Care. 2015;60:1397–1403.
-
- Fraser JF, Spooner AJ, Dunster KR, et al. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax. 2016;71:759–761.
-
- Braunlich J, Mauersberger F, Wirtz H. Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent. BMC Pulm Med. 2018;18:14.
-
- Delorme M, Bouchard PA, Simon M, et al. Physiologic effects of high-flow nasal cannula in healthy subjects. Respir Care. 2020;65:1346–1354.
-
- Sjöblom A, Hedberg M, Forsberg IM, et al. Comparison of preoxygenation using a tight facemask, humidified high-flow nasal oxygen and a standard nasal cannula—a volunteer, randomised, crossover study. Eur J Anaesthesiol. 2024;41:430–437.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
